2019 Mar – 2024 Feb | $7.09M

Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women (PYRAPREG) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao | Dem. Rep. Congo, Mozambique, Burkina Faso, Gambia, Mali

Similar Posts

  • 2018 Jan – 2019 Dec

    Establishment of an optimized in vitro screening platform for evaluation of antimalarial compounds against liver stages including hypnozoites of Plasmodium vivax and P. ovale using field isolated parasites Medicines for Malaria Venture (MMV), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Laurent Dembele | Ethiopia, Mali

  • 2013 Oct – 2014 Apr

    School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali National Center for Scientific and Technological Research (CNRST), Mali, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Ogobara Doumbo, Mahamadou S. Sissoko | Mali

  • 2017 Jun – 2019 May

    Characterization of Plasmodium falciparum gametocytes infectiousness determinants in Mali University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Dinkorma Ouologuem | Africa, Central, Africa, Eastern, Africa, Southern, Mali

  • WANECAM

    WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP). The WANECAM 2 project aims to accelerate the development of the  Ganaplacide/lumefantrine  combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries…

Leave a Reply

Your email address will not be published. Required fields are marked *